Simo Arredouani, Ph.D.

Instructor, Department of Surgery, Harvard Medical School

Staff Ph.D., Surgery, Beth Israel Deaconess Medical Center

Contact Info

Mohamed Arredouani
Beth Israel Deaconess Medical Center
330 Brookline Ave.

Boston, MA, 02215
Phone: 617-735-2102
Fax: 617-735-2110
marredou@bidmc.harvard.edu

Assistant

Not Available.

DF/HCC Program Affiliation

Research Abstract

Publications

• Arredouani MS, Lu B, Bhasin M, Eljanne M, Yue W, Mosquera JM, Bubley GJ, Li V, Rubin MA, Libermann TA, Sanda MG.Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.Clin
  19737960
• Haram KM,Peltier HJ,Lu B,Bhasin M,Otu HH,Choy B,Regan M,Libermann TA,Latham GJ,Sanda MG,Arredouani MS.Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclin
  18668517
• Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.Prostate 2008 Feb 26.
  18302222
• Tseng-Rogenski SS, Arredouani MS, Neeley YC, Lu B, Chinnaiyan AM, Sanda MG.Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer.Cancer Immunol Immunother 2008 Feb 12.
  18265979
• De Vleeschouwer S, Arredouani M, Adé M, Cadot P, Vermassen E, Ceuppens JL, Van Gool SW.Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.Cancer Immunol Immunother 2005 Apr;54(4):372-82.
  15692847